{"id":824052,"date":"2025-03-11T07:04:51","date_gmt":"2025-03-11T11:04:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/"},"modified":"2025-03-11T07:04:51","modified_gmt":"2025-03-11T11:04:51","slug":"tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/","title":{"rendered":"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEUM\u00dcNSTER, Germany, March  11, 2025  (GLOBE NEWSWIRE) &#8212; Tilray Medical (\u201cTilray\u201d), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of <strong>Tilray Craft<\/strong>, a new brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany.<\/p>\n<p>Tilray Craft is being introduced to address the evolving needs of patients in Germany for flower-based medical cannabis. The brand aims to offer unique flower options that are not currently available in the market, particularly targeting patients who require medical cannabis flower with higher THC and higher terpene content derived from novel genetic lineages. The latest product introduced under the Tilray Craft brand is <strong>Cannabisbl\u00fcten THC 25 TAM<\/strong><strong>.<\/strong><\/p>\n<p>Product details for Tilray Craft, Cannabisbl\u00fcten THC 25 TAM, include:<\/p>\n<ul type=\"disc\">\n<li>Strain: Triangle Mints<\/li>\n<li>Terpene Content:\u00a02.9%<\/li>\n<li>Type:\u00a0Sativa-leaning hybrid<\/li>\n<li>Genetics:\u00a0Cross of Triangle Kush and Animal Mints<\/li>\n<li>Flavor Profile:\u00a0Herbal, spicy, and earthy with diesel undertones<\/li>\n<\/ul>\n<p>Denise Faltischek, Chief Strategy Officer and Head of International at Tilray Brands, stated, &#8220;Our commitment to innovation in medical cannabis, alongside our unwavering dedication to patient care, guides our every endeavor. The launch of Tilray Craft and our new genetics, highlights our efforts to provide patients and healthcare professionals with high-quality, effective, and safe medical cannabis products. We continually assess our portfolio in collaboration with healthcare providers to address the evolving needs of our patients globally.&#8221;<\/p>\n<p>Tilray Craft&#8217;s medical cannabis products, including the Tilray Craft, Cannabisbl\u00fcten THC 25 TAM, are now available across Germany with a physician&#8217;s prescription at pharmacies.<\/p>\n<p>\n        <strong>About Tilray Medical<\/strong>\n      <\/p>\n<p>Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Medical,\u00a0Broken Coast, Redecan, Good Supply and Navcora. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in\u00a0Canada\u00a0to building the first GMP-certified cannabis production facilities in\u00a0Portugal\u00a0and\u00a0Germany. Today, Tilray Medical is a leading supplier of medical cannabis with a portfolio of brands and products designed to meet the needs of our patients worldwide.<\/p>\n<p>For further information on Tilray Medical, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w8_my4_MDz68yHWqs5Uzapb_YBtR5C2qW4xsexArvJ0ALyZIR-Xo4U7Z2pQPLrusNHQ-vFlkqx2uUqGTAN4OwZZLXXQLO_UXJXJtIwuvz6OQrayZ78yY9LoddRe3-DdDBFInlOEm4rL1InErcPZYnsrdr_FSMTohzR9i2EufC2gncYYhpXWnAVovSHgBIpLpHe7L1h24k7v9PTSZIj0Re5pasHQ8nbuE7truxTP-8ivkIOMh_dCTH7asAp8tKrGaXJZZ35Nw-3WBlh-88mo0DxoPhLBpB4tHwUYAAMnOP9X8kdwsPcNuNGiuyefKImZV4TdQH-H8PIToMMp-HhKQLYh9G8-ksb_dgoaeBywZqkE6cszLEXDOju_DcJ7QIbxTe7E6vhB6pFAAitOXDXjqCOP-n4GU-EEMdZjDZfbChdmsOSfezsZi5qK59yu3Ci7BGpL-ZSPnhxiSxE8ARDsDTW2WJcsTFDPqf8u0HYncUAjaqIMhCkWmfPp9sV5h3vlT\" rel=\"nofollow\" target=\"_blank\">Tilray Medical Europe<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w8_my4_MDz68yHWqs5UzakH3o8Tit7m6zg11GK9Lv76kEPgL7gQwwFjh03ixpVeK9J0OMZIk4kZpHH4Wx2FFDwznTNmFdBg9rYEVJxaWknP5UKve4CU4-HSC5BB3_KUZo32VhBEMV3xTlF14LeHCtEWB3Uel2Vda05tyzvYkAVBkwrtUdtFmGynguTEHlNBO2uFpTD8p_CRa_PmguLo9KJbGTL-5CoAUWdogKCHzuQ_irMyXubxxIRClPcbZ0GIblIRZL0aFgFC-7aMvVRhVikLED8zQxcbIoELT3C0R_IxLSlfEU6qx5ZWqx51-AjdVnyNyRy_Z8OpzxhbpEueO6D6V1XDXXUmoX4o-m1s6hEogSYkqp9Xb9W1kH_r6wF5wId3Hs1JjwXpBdyehltBxpmvfcLU0_mNEFvXhGvJpgUNYGqtFtw50dXxuio8CNqP5b7r7tWPhDXxDKcy1IhlnisAEopHnFS9i0-brV8AYOyLv3PS_0lqaYUIbiH0EIe98\" rel=\"nofollow\" target=\"_blank\">Tilray Medical Canada<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w8_my4_MDz68yHWqs5Uzat71J5Rk6-udLwcyd6Z_2i_vFkkBVui4BQfHnKcUqlfr4mVYh7un0TDwYGjVT7YQIX4XAAdhU8G_8cF2AaFoDXppoVJhWpcJtVMKPZ9ee_HddjFLquB6tXdvkc7TYy3qdTUPCxRStG0Cb5sOptV1YZrZioHktRyDQpHbxhCc7fQpZvgCo663s5oV96a5m5AgmHqs6dCdQVAEYvEOrNLNCGbZmMXeKlI7JFVplnL_oBKX3AjmX4AmTcy5L4jqoTiRW1avCGQp8CJuG53VOxPHpspi1zAfkklLuARdxC4TRT0LhTU0m3oLpe1dGi6m0WgA5sQTaLFldgI5rDfFJYGQwVzKV5rVkuxt89-Wx_OjdC87uJArpUBcB_GmPqD_HT1JeWp6sNkLLm6DukdPKUwHOqhoiAO6K0SXwJ-S7FDPgzCuGFQO4OUgGQo649d7X-qA4h40c0EK0Z8zmwLxS8tObLpvM3mZRKKQ8gUKWz6Q-8KU0v-TNi8b3pzCRfy35BNNhF-XJ67dZni8ECZuMVrGiXOYeUsRljy5GCwTA92R1WcU\" rel=\"nofollow\" target=\"_blank\">Tilray Medical Australia-New Zealand<\/a>.<\/p>\n<p>\n        <strong>About\u00a0Tilray Brands<\/strong>\n      <\/p>\n<p>Tilray Brands, Inc.\u00a0(\u201cTilray\u201d) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in\u00a0Canada,\u00a0the United States,\u00a0Europe,\u00a0Australia, New Zealand and\u00a0Latin America\u00a0that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray\u2019s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray\u2019s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.<\/p>\n<p>For more information on how we are elevating lives through moments of connection, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w8_my4_MDz68yHWqs5UzatAscwmshlQOP4xViuHssgULHx6I2fz3r94D1B5F1cLUaNrnHPCeX3JTiJz2SEFeQLd7EMvOkaHy3BmyPnE4taXXcSfxDQPynZQ1dIQzxYiHSPx561eJrnziluyrOqGAznr6Nxgg-mb7rcYc47KMBA7DMJzijZDIJjnvbb6evghd2dYYwrQKB_tB07fD48i_E2lFy_tvbuFMcH9QyvXELexyJQSG1XoUWJOTJVlk5lJC2N74-YvrvooAc4JXpAlmMH9vEY3SPS_CCPvRsr-SdlGi5n-pNBFnVVR4gAoU_QNh09uTZ714umtIZD5qhAK6Fkmtv-GLIyjzHwuwrk7r4UIuI4OaWkw1Ga3gXxjhTaitf7in1O5lgs25N-IrLknY9dO31d9-hWf1d91K9nw6yDxFMV0Jm8jkEAK1DO-tkCKT-nuxk2PDzD2FbXs-OCipAtiPFuFsUF7C_9T7MwGdVPBoyIuhP57ygH337znfruGPfEX4Iww9naGf2VHGWD1asauGqwSeX5wWwR6yEmhbJfwIbDyMTw71JLFWFd4xDTEyQS_pylj065R2H005jHYEPYZ0Womp733uvw1PvhIaNgtF13_LdqXEvmq0iHKd47yMPvKu99wcigXzisgyaCY5GTie2m3D_eQlYqa4NAHqJfc=\" rel=\"nofollow\" target=\"_blank\">Tilray.com<\/a>\u00a0and follow @Tilray on all social platforms.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, \u201cforward-looking statements\u201d) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the \u201csafe harbor\u201d created by those sections and other applicable laws. Forward-looking statements can be identified by words such as \u201cforecast,\u201d \u201cfuture,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cenable,\u201d \u201cpotential,\u201d \u201ccontemplate,\u201d \u201cbelieve,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cproject,\u201d \u201cwill,\u201d \u201cwould\u201d and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company\u2019s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of\u00a0Tilray\u00a0and the Annual Report on Form 10-K (and other periodic reports filed with the\u00a0SEC) of\u00a0Tilray\u00a0made with the\u00a0SEC\u00a0and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.<\/p>\n<p>\n        <strong>For further information:<\/strong><br \/>\n        <br \/>Media:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cIhPYwYTIrfa7K5WLsZXJCUYJC5qaRVLgw-QIAvzTzJ3BuMISjG0_zxJuKquTVuFP6zoxwv2Ddpl-4IR8YOHiioK5UFJ-rmcfOXJP-SkJ_DxYAyFt1SJmoGqjpiGrvCkbr38DDwNs9hEqnbb2pgVjt-Qmj4pLKoUIpO1zNnpDAoUVHqOeSOTEuu-Ejo27v39SEJzvORf04B0c7GO8ja-_4HkSRg672YXNfbtYPHA3QnqAR_3GAwZGnvIShCmbvuEUoIUv4OqcmNDTkc86UhrsQXGNKNX4vQtlLJ-2iWr_MZQq62EAzOIhwt5qimlgLTUYPgoy26W4jk36w_NHJszGo2mQC59Mn0f8dBwkmMwC-HTi6rWWm2ENHyX25ef8qeC06-XOssuWDXh2XNtXUNz87v1T25zrik3kX9qNn_XepVE-XcnpfIon3iG076wkriS\" rel=\"nofollow\" target=\"_blank\">news@tilray.com<\/a><br \/>Investor Relations:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PPkEMJBNUPU66OO2ap0nrysmp5qctSBja4mSlji_2wKGyr4kQcmtlTJvBIg1WWXVkvhscOQxr-CSYKIO4uPplT4-6JA80BOz19x5chhtCW7qs26T2syHnDz3rKeR7wWGtXesyHB02ZTT3d8oya1cPu23WUFWeyeYwQQjA9saL_rBxrmtz6hX5RiDpR4a2T3qZWDgenvlm3bqvQqdADF8U8bnEE2_VnyTIsFNXwVpHDMCh3CQymgXsFHSLqE7mT0UBXZJsdeaYNxgoFDUHXby99G7SABnzXGf9FM3I5IoYcdV22CcnwMD8-q6mjwsulYw2TIqWMXA0d2z5Xr52Gg13AwJCPAx3uopKvopK7jp4Wy70txpoMAN8o2Tr8mFteUMvYLXSgmFX1_NzZ0MpIadqi7rJ2EWANvchRde_x-ENZbUTG1kJDkfkDkZ1ZJ8o_JF5B8ART_6AUBEuKMivzwkVGOlH02dHPTPODsM4LtmirUnm1w1iuXthn0js_94Z5mO\" rel=\"nofollow\" target=\"_blank\">investors@tilray.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGVhNzlhY2QtMDNlNy00ZDAxLTg5MDUtMzYzNTZiNmY5OWY1LTEyMzU1NTEtMjAyNS0wMy0xMS1lbg==\/tiny\/Tilray-Brands-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEUM\u00dcNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) &#8212; Tilray Medical (\u201cTilray\u201d), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of Tilray Craft, a new brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany. Tilray Craft is being introduced to address the evolving needs of patients in Germany for flower-based medical cannabis. The brand aims to offer unique flower options that are not currently available in the market, particularly targeting patients who require medical cannabis flower with higher THC and higher terpene content &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-824052","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEUM\u00dcNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) &#8212; Tilray Medical (\u201cTilray\u201d), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of Tilray Craft, a new brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany. Tilray Craft is being introduced to address the evolving needs of patients in Germany for flower-based medical cannabis. The brand aims to offer unique flower options that are not currently available in the market, particularly targeting patients who require medical cannabis flower with higher THC and higher terpene content &hellip; Continue reading &quot;Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-11T11:04:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market\",\"datePublished\":\"2025-03-11T11:04:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/\"},\"wordCount\":850,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/\",\"name\":\"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=\",\"datePublished\":\"2025-03-11T11:04:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/","og_locale":"en_US","og_type":"article","og_title":"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market - Market Newsdesk","og_description":"NEUM\u00dcNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) &#8212; Tilray Medical (\u201cTilray\u201d), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of Tilray Craft, a new brand extension of the Tilray Medical brand within its medical cannabis portfolio in Germany. Tilray Craft is being introduced to address the evolving needs of patients in Germany for flower-based medical cannabis. The brand aims to offer unique flower options that are not currently available in the market, particularly targeting patients who require medical cannabis flower with higher THC and higher terpene content &hellip; Continue reading \"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-11T11:04:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market","datePublished":"2025-03-11T11:04:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/"},"wordCount":850,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/","name":"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=","datePublished":"2025-03-11T11:04:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MjE2NyM2Nzk5NTY0IzIyMjM5OTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medical-cannabis-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=824052"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824052\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=824052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=824052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=824052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}